EUROPE STEM CELL MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

EUROPE STEM CELL MARKET 2021-2028

Market by Therapeutic Application, Technology, Treatment Type, Product, Application, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton’s report, the European stem cell market is likely to attain a CAGR of 7.75% in terms of revenue through the projected years of 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries scrutinized in this market include:

•        The UK

•        Spain

•        Germany

•        Italy

•        France

•        Russia

•        Rest of Europe

In Germany, the number of patients with dementia is anticipated to surge in the near future, further augmenting the stem cell market’s progress. With the surge in the incidences of neurological dementia, several companies are involved in the development of novel effective stem cell therapies. Additionally, the German Stem Cell Network’s target is to create interactions with the field of regenerative medicines, further to launch innovative national and foreign research activities and alliances. Thus, such developments are likely to propel the stem cell market on a growth path.

The pharmaceutical and healthcare sectors in Russia hold more significant potential for efficient stem cell studies and clinical trials. Moreover, the rapid patient enrollment, higher clinical trial participation, and favorable currency exchange rates, are among the country’s strengths. Here, quick patient enrollment is a significant factor in initial-stage trials that would permit rapid project inductions. Hence, these aspects are anticipated to offer several new opportunities for the stem cell market to achieve its expected growth across Russia.

In Italy, the investments in R&D for the development of beneficial therapies for treating chronic diseases, along with clinical trials for stem cell therapy, is likely to proliferate in the near future, owing to the surge in the number of chronic conditions. Moreover, the pandemic outbreak has led Italian Bioscience Institute to develop a protocol for treating the virus, which is based on isolated and extended mesenchymal stem cells. Therefore, these factors are expected to offer lucrative opportunities for the stem cell market in Italy. 

Miltenyi Biotec manufactures cell labeling reagents, cell separation, and analysis tools and systems for clinical processes. Its product portfolio entails MACS sample preparations, cell separation, and cell culture and stimulations, and others. Moreover, the company’s research focuses on immunology, stem cell research, and cancer, among others. It has its operations across multiple regions, and has headquarter based in Germany. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    EUROPE STEM CELL MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1.   THREAT OF NEW ENTRANTS

2.1.2.   THREAT OF SUBSTITUTE PRODUCTS

2.1.3.   BARGAINING POWER OF BUYERS

2.1.4.   BARGAINING POWER OF SUPPLIERS

2.1.5.   COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON STEM CELL MARKET

2.3. KEY IMPACT ANALYSIS

2.4. INDUSTRY COMPONENTS

2.5. LEGAL, POLICY, & REGULATORY FRAMEWORK

2.6. MARKET ATTRACTIVENESS INDEX

2.7. VENDOR SCORECARD

2.8. KEY INSIGHTS

2.9. MARKET DRIVERS

2.9.1.   GROWING AWARENESS ABOUT UMBILICAL CORD STEM CELLS

2.9.2.   SURGE IN STEM CELL RESEARCH AND DEVELOPMENT

2.9.3.   RISING DEMAND FOR REGENERATIVE MEDICINE

2.10. MARKET RESTRAINTS

2.10.1.   ETHICAL CONCERNS ASSOCIATED WITH STEM CELLS

2.10.2.   HIGH COST OF STEM CELL PROCEDURES

2.10.3.    STRINGENT REGULATIONS IN TERMS OF STEM CELL THERAPY

2.11. MARKET OPPORTUNITIES

2.11.1.    ADVANCEMENT IN TECHNOLOGY

2.11.2.   RISK OF ADVERSE IMMUNE REACTIONS AND COMPLICATIONS

3.    EUROPE STEM CELL MARKET OUTLOOK - BY THERAPEUTIC APPLICATION

3.1. NEUROLOGICAL DISORDERS

3.2. ONCOLOGY DISORDERS

3.3. DIABETES

3.4. INJURIES AND WOUNDS

3.5. ORTHOPEDIC TREATMENTS

3.6. CARDIOVASCULAR DISORDERS

3.7. OTHER THERAPEUTIC APPLICATIONS

4.    EUROPE STEM CELL MARKET OUTLOOK - BY TECHNOLOGY

4.1. CRYOPRESERVATION

4.2. ACQUISITION

4.2.1.   STEM CELL APHERESIS

4.2.2.   STEM CELL BONE MARROW MARKET

4.2.3.   STEM CELL UMBILICAL CORD

4.3. EXPANSION AND SUB-CULTURE

4.4. PRODUCTION

4.4.1.   STEM CELL CULTURE

4.4.2.   THERAPEUTIC CLONING

4.4.3.   IVF

5.    EUROPE STEM CELL MARKET OUTLOOK - BY TREATMENT TYPE

5.1. ALLOGENEIC STEM CELL THERAPY

5.2. AUTOLOGIC STEM CELL THERAPY

5.3. SYNGENEIC STEM CELL THERAPY

6.    EUROPE STEM CELL MARKET OUTLOOK - BY PRODUCT

6.1. ADULT STEM CELL

6.1.1.   HEMATOPOIETIC STEM CELL

6.1.2.   NEURAL STEM CELL

6.1.3.   UMBILICAL CORD STEM CELL

6.1.4.   MESENCHYMAL STEM CELL

6.1.5.   DENTAL STEM CELL

6.2. HUMAN EMBRYONIC STEM CELL

6.3. PLURIPOTENT

6.4. MOUSE/RAT NEURAL

7.    EUROPE STEM CELL MARKET OUTLOOK - BY APPLICATION

7.1. REGENERATIVE MEDICINE

7.2. DRUG DISCOVERY AND DEVELOPMENT

8.    GEOGRAPHICAL ANALYSIS - EUROPE

8.1. COUNTRY ANALYSIS

8.1.1.   GERMANY

8.1.2.   FRANCE

8.1.3.   UNITED KINGDOM

8.1.4.   ITALY

8.1.5.   RUSSIA

8.1.6.   SPAIN

8.1.7.   REST OF EUROPE

9.    COMPANY PROFILES

9.1. CORNING INC

9.2. STEMCELL TECHNOLOGIES

9.3. STRYKER CORPORATION

9.4. BECTON DICKINSON AND COMPANY (BD)

9.5. CYTORI THERAPEUTICS

9.6. QIAGEN NV

9.7. GE HEALTHCARE

9.8. TAKARA HOLDINGS INC

9.9. SMITH & NEPHEW PLC

9.10. INTERNATIONAL STEM CELL CORP

9.11. MILTENYI BIOTEC

9.12. MERCK KGAA (SIGMA ALDRICH)

9.13. THERMO FISHER SCIENTIFIC INC

9.14. ALLCELLS LLC

9.15. PLURISTEM THERAPEUTICS INC

10. RESEARCH METHODOLOGY & SCOPE

10.1. RESEARCH SCOPE & DELIVERABLES

10.1.1.   OBJECTIVES OF STUDY

10.1.2.   SCOPE OF STUDY

10.2. SOURCES OF DATA

10.2.1.   PRIMARY DATA SOURCES

10.2.2.   SECONDARY DATA SOURCES

10.3. RESEARCH METHODOLOGY

10.3.1.   EVALUATION OF PROPOSED MARKET

10.3.2.   IDENTIFICATION OF DATA SOURCES

10.3.3.   ASSESSMENT OF MARKET DETERMINANTS

10.3.4.   DATA COLLECTION

10.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        EUROPE STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2        VENDOR SCORECARD

TABLE 3        EUROPE STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 4        EUROPE STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 5        EUROPE ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6        EUROPE PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 7        EUROPE STEM CELL MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)

TABLE 8        EUROPE STEM CELL MARKET, BY PRODUCT, 2021-2028, (IN $ MILLION)

TABLE 9        EUROPE ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 10      EUROPE STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 11      EUROPE STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1      EUROPE STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 2      EUROPE STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 3      EUROPE STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 4      EUROPE STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION)

FIGURE 5      EUROPE STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)

FIGURE 6      EUROPE STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)

FIGURE 7      EUROPE STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 8      EUROPE STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 9      EUROPE STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)

FIGURE 10   EUROPE STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION)

FIGURE 11   EUROPE STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 12   EUROPE STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)

FIGURE 13   EUROPE STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)

FIGURE 14   EUROPE STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)

FIGURE 15   EUROPE STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION)

FIGURE 16   EUROPE STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION)

FIGURE 17   EUROPE STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)

FIGURE 18   EUROPE STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION)

FIGURE 19   EUROPE STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 20   EUROPE STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 21   EUROPE STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 22   EUROPE STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 23   EUROPE STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 24   EUROPE STEM CELL MARKET, BY NEURAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 25   EUROPE STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 26   EUROPE STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 27   EUROPE STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 28   EUROPE STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 29   EUROPE STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION)

FIGURE 30   EUROPE STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)

FIGURE 31   EUROPE STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 32   EUROPE STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)

FIGURE 33   GERMANY STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 34   FRANCE STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 35   UNITED KINGDOM STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 36   ITALY STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 37   RUSSIA STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 38   SPAIN STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 39   REST OF EUROPE STEM CELL MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;